Newsletter Archive

31. 05.26.20 -- Considerations For Clinical Supply Efficiency 5/26/2020
    05/26/20 Clinical Leader Newsletter
32. 05.21.20 -- Effective Strategies For Biotech Studies 5/21/2020
    05/21/20 Clinical Leader Newsletter
33. 05.20.20 -- What To Expect From The FDA During (And After) COVID-19 5/20/2020
    05/20/20 Clinical Leader Newsletter
34. 05.18.20 -- Adjusting To Clinical Trial Remote Monitoring During COVID-19: Working Smarter & Safer 5/18/2020
    05/18/20 Clinical Leader Newsletter
35. 05.14.20 -- Boosting Support To Sites During The Pandemic 5/14/2020
    05/14/20 Clinical Leader Newsletter
36. 05.13.20 -- COVID-19 Presents Unique Challenges For Oncology Trials 5/13/2020
    05/13/20 Clinical Leader Newsletter
37. 05.12.20 -- Overcome Disruptions To Clinical Trials Caused By COVID-19 5/12/2020
    05/12/20 Clinical Leader Newsletter
38. 05.11.20 -- Post COVID-19: Clinical Trials Will Never Be The Same 5/11/2020
    05/11/20 Clinical Leader Newsletter
39. 05.09.20 -- Despite COVID-19, Patients Are Interested In New Trials 5/9/2020
    05/09/20 Clinical Leader Newsletter
40. 05.07.20 -- Preparing Your Study For Post-COVID-19 5/7/2020
    05/07/20 Clinical Leader Newsletter